Litigation Details for Braintree Laboratories, Inc. v. Lannett Company, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Braintree Laboratories, Inc. v. Lannett Company, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-03-20 |
| Court | District Court, D. Delaware | Date Terminated | 2017-12-14 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 6,946,149 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Braintree Laboratories, Inc. v. Lannett Company, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Braintree Laboratories, Inc. v. Lannett Company, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-03-20 | 1 | infringement of U.S. Patent No. 6,946,149, as reexamined (“the ʼ149 patent”), arising under the patent laws of the… claims of the ’149 patent. THE ’149 PATENT 13. Braintree…issued by the U.S. Patent and Trademark Office on September 20, 2005. The ’149 patent was the subject of…an amended claim, were patentable. A true and correct copy of the ’149 patent and its reexamination certificate…interest in the ’149 patent, possesses the right to sue for infringement of the ’149 patent. | External link to document | |
| 2017-03-20 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,946,149. (ceg) (Entered: 03… 15 December 2017 1:17-cv-00293 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
